Latest HIV/AIDS Stories
LONDON, April 16, 2013 /PRNewswire/ -- Antibody Treatment for HIV SEEK, a privately-owned UK drug discovery group, announces that pre-clinical results on its HIV immunotherapy have been published in the peer-reviewed journal Virology Journal. SEEK's HIV immunotherapy triggers the immune system's cellular and antibody responses to selectively identify and kill HIV infected cells. The most exciting aspect of this therapy is that it...
Blocking a key protein boosts body's ability to clear chronic infection UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection. Published in the April 12 edition of Science, the finding suggests new approaches to treating persistent viral infections like HIV and hepatitis C. The research team studied type-1 interferons (IFN-1), proteins released by cells in response to disease-causing organisms...
A simple in-home training program for caregivers can give children of AIDS patients a better shot at prosperity by improving their early-childhood development, according to a study led by a Michigan State University researcher. Michael Boivin, MSU associate professor in the departments of Psychiatry, and of Neurology and Ophthalmology, conducted the research in Uganda, where about one million children have lost at least one parent to AIDS – an unlucky club that adds another member every...
Proposes Increases for Care, Medications and Prevention WASHINGTON, April 10, 2013 /PRNewswire-USNewswire/ -- "The budget President Obama outlined today yet again demonstrates his strong commitment to ending HIV by increasing funding for prevention and lifesaving care and treatment for those who cannot afford it in the United States," commented Carl Schmid, Deputy Executive Director of The AIDS Institute. "President Obama and his Administration recognize the importance of the...
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count drops below 200 (cells per microliter), according to a study by South African researchers published in this week's PLOS Medicine. These findings are encouraging and show that with long-term treatment, HIV can be managed as a chronic illness in middle- and low-income...
Inovio to Advance Painless Device to Simultaneously Deliver Multiple Vaccines Using Electroporation Technology BLUE BELL, Pa., April 10, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has been selected to receive a $3.5 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance the development of its next generation DNA vaccine delivery device capable of simultaneously administering multiple synthetic vaccines via skin surface...
Brett Smith for redOrbit.com - Your Universe Online When HIV enters the human body, it begins an arms race with the immune system which is constantly attempting to develop new ways to destroy the invader. Unfortunately, the body is at some point overwhelmed by a multitude of HIV mutations before the immune system is able to develop a superweapon against the virus. However, some immune systems do develop a superweapon called "broadly neutralizing antibodies” a few years after the...
A new international study has confirmed that self-testing for HIV is effective and could be the answer to controlling the global epidemic. This major systematic review, led by the Research Institute of the McGill University Health Centre (RI-MUHC), shows HIV self-testing removes much of the fear and stigma associated with being tested for the disease. This study, which is published in PLoS Medicine is the first of its kind and could pave the way for early detection and treatment around the...
LOS ANGELES, April 2, 2013 /PRNewswire/ -- One of the most guarded projects in Hollywood over the last 7 years was not on the Harry Potter set or at the next episode of Breaking Bad. There has been a more closely guarded project with a development team a few blocks south of SONY Studios in a secured fortress, a former impenetrable, high security communications center in the non-descript, brick EDG building in Culver City, CA. The high security location required access by fingerprint...
DUBLIN, April 2, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "HIV-AIDS Testing Markets" report to their offering. There are an estimated 33.3 million people living with HIV (the virus which causes AIDS) worldwide and approximately 2.6 million people are newly-infected each year. While the Asian and African regions account for more than 90% of the HIV-infected population (with the highest number in Sub-Saharan Africa), the U.S. and European regions make up...
Latest HIV/AIDS Reference Libraries
The Journal of Acquired Immune Deficiency Syndromes is a peer-reviewed medical journal established in 1988 and is currently published by Lippincott Williams & Wilkins. The journal was renamed ‘Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology’ in 1995, and then returned to its original title in 1999. The journal was the official publication of the International Retrovirology Association until 2000. This journal covers aspects of research in HIV/AIDS, including...
AIDS is a peer-reviewed scientific journal published 18 times yearly by Lippincott Williams & Wilkins, London, UK. It was established in 1987 and is the official journal of the International AIDS Society. It covers all aspects of HIV and AIDS research, including basic science, clinical trials, epidemiology, and social science. As of May 2012, the editor-in-chief is Jay A. Levy. AIDS has been cited as the most read journal in its area of science and has the highest impact of all...
Simian immunodeficiency virus (SIV), also known as African Green Monkey virus, is a retrovirus able to infect at least 33 species of African primates. SIV has been present in monkeys and apes for at least 32,000 years, probably longer. Strains from two of these primate species have crossed the barriers into humans resulting in HIV-2 and HIV-1. Contraction involves contact with the blood of chimps that are often hunted for bushmeat in Africa. SIV infections appear in many cases to be...
Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...
Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...
